Development of Parkinson's disease in patients with Narcolepsy

16Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Although amphetamine drugs can damage dopaminergic axons, it is unknown whether chronic treatment with amphetamine increases the risk of developing Parkinson's disease (PD). Of 1,152 consecutive PD patients, 3 had a prior diagnosis of narcolepsy. This rate is five times higher than expected (p = 0.02). These patients had typical onset of narcolepsy and underwent treatment with amphetamine. Although preliminary, this observation raises the possibility that some factors intrinsic to narcolepsy or its treatment may be a risk factor for PD. © Springer-Verlag 2012.

Cite

CITATION STYLE

APA

Christine, C. W., Marks, W. J., & Ostrem, J. L. (2012). Development of Parkinson’s disease in patients with Narcolepsy. Journal of Neural Transmission, 119(6), 697–699. https://doi.org/10.1007/s00702-011-0761-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free